Gregory W. Sluggett

New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities

Martin A. Ott, Andrew Teasdale, Michael J. Burns, 2019, Organic Process Research & Development.

A Design Space Verification Protocol for a Small Molecule Drug Substance

Roger Nosal, Thomas P. Garcia, Timothy J. N. Watson, 2013, Journal of Pharmaceutical Innovation.

Kinetic Modeling of API Oxidation: (1) The AIBN/H2O/CH3OH Radical "Soup".

Gregory W. Sluggett, Geoffrey P. F. Wood, Frank C. Pickard, 2021, Molecular pharmaceutics.

EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin.

Gregory W. Sluggett, Cynthia L Stevenson, C. Stevenson, 2005, Diabetes technology & therapeutics.

Development and validation of a sensitive GC-MS method for the determination of trace levels of an alkylating reagent in a beta-lactam active pharmaceutical ingredient.

Gregory W. Sluggett, Hanlin Li, 2005, Journal of pharmaceutical and biomedical analysis.

Development and validation of a GC method for quantitative determination of enantiomeric purity of a proline derivative.

Gregory W. Sluggett, G. Sluggett, Y. Xiang, 2010, Journal of pharmaceutical and biomedical analysis.